EAISX | MDIHX | EAISX / MDIHX | |
Total Expense Ratio | 0.78 | 1.08 | 72% |
Annual Report Gross Expense Ratio | 0.88 | 1.10 | 80% |
Fund Existence | 16 years | 21 years | - |
Gain YTD | 25.512 | 23.859 | 107% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 287M | 44B | 1% |
Annual Yield % from dividends | 2.65 | 1.87 | 142% |
Returns for 1 year | 15.65 | 15.60 | 100% |
Returns for 3 years | 58.99 | 60.31 | 98% |
Returns for 5 years | 40.15 | 39.27 | 102% |
Returns for 10 years | 66.29 | 105.29 | 63% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FINSX | 50.97 | 0.06 | +0.12% |
Fidelity Advisor New Insights I | |||
FIRCX | 10.04 | 0.01 | +0.10% |
Fidelity Advisor Intl Real Estate C | |||
NBHAX | 15.14 | 0.01 | +0.07% |
Neuberger Berman Equity Income A | |||
BIPSX | 29.24 | -0.05 | -0.17% |
ProFunds Biotechnology UltraSector Svc | |||
GEMCX | 24.24 | -0.05 | -0.21% |
Goldman Sachs Emerging Markets Eq C |